PRESAGE BIOSCIENCES, INC.

A Pioneer In Translational Oncology

Seattle, United States · Founded 2016 · $19.0M raised

Founded
2016
Business Model
B2B
Total Funding
$19.0M
Last Round
$13.0M Corporate RoundMar 2021
Rounds
2

About

Presage Biosciences is a translational oncology company pioneering the CIVO platform, which delivers microdoses of multiple drug candidates simultaneously into living tumors to evaluate their effectiveness in situ. This in vivo approach captures the patient's own immune system and tumor microenvironment to generate more predictive data for cancer drug development. Presage collaborates with pharmaceutical partners to accelerate oncology drug discovery.

Summary

PRESAGE BIOSCIENCES, INC. is a Biotech company based in Seattle, United States, founded in 2016. It has raised $19.0M in total across 2 rounds, most recently a $13.0M Corporate Round round in Mar 2021. Investors include Celgene Corporation, Takeda (JP) and Bristol Myers Squibb.

Tech & App Stack

3 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Corporate RoundCorporate RoundMar 2021
$13.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PRESAGE BIOSCIENCES, INC. on Indexed.vc
<a href="https://indexed.vc/companies/presage-biosciences-inc"><img src="https://indexed.vc/api/badge/company/presage-biosciences-inc" alt="PRESAGE BIOSCIENCES, INC. on Indexed.vc" width="260" height="76" /></a>